Skip to main content
. 2015 Oct 6;10(10):e0136703. doi: 10.1371/journal.pone.0136703

Fig 3. Up-regulation of miR-29a attenuates TGF-β1-mediated cholangiocarcin- oma cell growth.

Fig 3

Cell proliferation assay was performed in FRH–0201 (A) and CCLP–1 (B) cells, 48h after transfection with anti-miR-29a. When the two tumor cell lines were treated with miR-29a mimic, cell proliferation assay was performed after additional treatment with 5ng/ml TGF-β1 for 48h. Data are shown as mean±SD; *p<0.05;**P<0.01.